The UK Cardiac and Vascular Surgery Interventional Anaemia Response (CAVIAR) Study: protocol for an observational cohort study to determine the impact and effect of preoperative anaemia management in cardiac and vascular surgical patients

被引:21
作者
Chau, Marisa [1 ]
Richards, Toby [1 ]
Evans, Caroline [2 ]
Butcher, Anna [1 ]
Collier, Timothy [3 ]
Klein, Andrew [4 ]
机构
[1] UCL, Div Surg & Intervent Sci, London, England
[2] Cardiff & Vale Univ Hlth Board, Cardiff, S Glam, Wales
[3] London Sch Hyg & Trop Med, Dept Med Stat, London, England
[4] Papworth Hosp, Dept Anaesthesia, Cambridge, England
来源
BMJ OPEN | 2017年 / 7卷 / 04期
关键词
IRON-DEFICIENCY ANEMIA; INTRAVENOUS IRON; HEART-FAILURE; NONCARDIAC SURGERY; TRANSFUSION; ASSOCIATION; DISEASE; SUPPLEMENTATION; MORTALITY; ENDURANCE;
D O I
10.1136/bmjopen-2016-014872
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Preoperative anaemia is linked to poor postsurgical outcome, longer hospital stays, greater risk of complications and mortality. Currently in the UK, some sites have developed anaemia clinics or pathways that use intravenous iron to correct iron deficiency anaemia prior to surgery as their standard of care. Although intravenous iron has been observed to be effective in a variety of patient settings, there is insufficient evidence in its use in cardiac and vascular patients. The aim of this study is to observe the impact and effect of anaemia and its management in patients undergoing cardiac and vascular surgery. In addition, the UK Cardiac and Vascular Surgery Interventional Anaemia Response (CAVIAR) Study is also a feasibility study with the aim to establish anaemia management pathways in the preoperative setting to inform the design of future randomised controlled trials. Methods and analysis The UK CAVIAR Study is a multicentre, stepped, observational study, in patients awaiting major cardiac or vascular surgery. We will be examining different haematological variables (especially hepcidin), functional capacity and patient outcome. Patients will be compared based on their anaemia status, whether they received intravenous iron in accordance to their hospital's preoperative pathway, and their disease group. The primary outcomes are the change in haemoglobin levels from baseline (before treatment) to before surgery; and the number of successful patients recruited and consented (feasibility). The secondary outcomes will include changes in biomarkers of iron deficiency, length of stay, quality of life and postoperative recovery. Ethics and dissemination The study protocol was approved by the London-Westminster Research Ethics Committee (15/LO/1569, 27 November 2015). NHS approval was also obtained with each hospital trust. The findings of the study will be published in peer-reviewed journals.
引用
收藏
页数:7
相关论文
共 21 条
  • [21] PRE-OPerative ECHOcardiograhy for prevention of cardiovascular events after non-cardiac surgery in intermediate- and high-risk patients: protocol for a low-interventional, mixed-cohort prospective study design (PREOP-ECHO)
    Eun Kyoung Kim
    Hong-Mi Choi
    Eui-Young Choi
    Hye Sun Lee
    Goeun Park
    Dong Woo Han
    Sang-Eun Lee
    Chan Seok Park
    Ji-won Hwang
    Jae Hyuk Choi
    Mi-Na Kim
    Hyung-Kwan Kim
    Dae-Hee Kim
    Sung-Hee Shin
    Il Suk Sohn
    Mi-Seung Shin
    Jin Oh Na
    Iksung Cho
    Sun Hwa Lee
    Yong Hyun Park
    Tae-Ho Park
    Kye Hun Kim
    Goo-Young Cho
    Hae Ok Jung
    Dae-Gyun Park
    Ji Yeon Hong
    Duk-Hyun Kang
    Trials, 23